These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 37403830)

  • 1. Barriers and facilitators to genetic testing for breast and ovarian cancer amongst Black African women in Luton (UK).
    Kabeya V; Puthussery S; Furmanski A
    J Genet Couns; 2024 Apr; 33(2):425-444. PubMed ID: 37403830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What Black Women Know and Want to Know About Counseling and Testing for BRCA1/2.
    Adams I; Christopher J; Williams KP; Sheppard VB
    J Cancer Educ; 2015 Jun; 30(2):344-52. PubMed ID: 25301325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers to early diagnosis of symptomatic breast cancer: a qualitative study of Black African, Black Caribbean and White British women living in the UK.
    Jones CE; Maben J; Lucas G; Davies EA; Jack RH; Ream E
    BMJ Open; 2015 Mar; 5(3):e006944. PubMed ID: 25770231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of Malay cultural beliefs on breast cancer screening and genetic testing: A focus group study.
    Shaw T; Ishak D; Lie D; Menon S; Courtney E; Li ST; Ngeow J
    Psychooncology; 2018 Dec; 27(12):2855-2861. PubMed ID: 30264524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic counseling and testing for breast cancer risk in African Americans.
    Halbert CH
    LDI Issue Brief; 2006 Sep; 12(1):1-4. PubMed ID: 17302016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing Disparities in Receipt of Genetic Counseling for Underserved Women at Risk of Hereditary Breast and Ovarian Cancer.
    Sutton AL; Hurtado-de-Mendoza A; Quillin J; Rubinsak L; Temkin SM; Gal T; Sheppard VB
    J Womens Health (Larchmt); 2020 Aug; 29(8):1131-1135. PubMed ID: 31794334
    [No Abstract]   [Full Text] [Related]  

  • 7. "Girl, just pray …": Factors That Influence Breast and Cervical Cancer Screening Among Black Women in Rochester, MN.
    Sage SK; Hawkins-Taylor C; Crockett RA; Balls-Berry JE
    J Natl Med Assoc; 2020 Oct; 112(5):454-467. PubMed ID: 30935680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk perception, safer sex practices and PrEP enthusiasm: barriers and facilitators to oral HIV pre-exposure prophylaxis in Black African and Black Caribbean women in the UK.
    Nakasone SE; Young I; Estcourt CS; Calliste J; Flowers P; Ridgway J; Shahmanesh M
    Sex Transm Infect; 2020 Aug; 96(5):349-354. PubMed ID: 32532928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Black and Minority Ethnic women's decision-making for risk reduction strategies after BRCA testing: Use of context and knowledge.
    Machirori M; Patch C; Metcalfe A
    Eur J Med Genet; 2019 May; 62(5):376-384. PubMed ID: 30550831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knowledge, attitudes, and interest in breast-ovarian cancer gene testing: a survey of a large African-American kindred with a BRCA1 mutation.
    Kinney AY; Croyle RT; Dudley WN; Bailey CA; Pelias MK; Neuhausen SL
    Prev Med; 2001 Dec; 33(6):543-51. PubMed ID: 11716649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of acculturation and breast cancer-specific distress on perceived barriers to genetic testing for breast cancer among women of African descent.
    Sussner KM; Thompson HS; Jandorf L; Edwards TA; Forman A; Brown K; Kapil-Pair N; Bovbjerg DH; Schwartz MD; Valdimarsdottir HB
    Psychooncology; 2009 Sep; 18(9):945-55. PubMed ID: 19090507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethnic, racial and cultural identity and perceived benefits and barriers related to genetic testing for breast cancer among at-risk women of African descent in New York City.
    Sussner KM; Edwards TA; Thompson HS; Jandorf L; Kwate NO; Forman A; Brown K; Kapil-Pair N; Bovbjerg DH; Schwartz MD; Valdimarsdottir HB
    Public Health Genomics; 2011; 14(6):356-70. PubMed ID: 21540561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why Is Cancer Genetic Counseling Underutilized by Women Identified as at Risk for Hereditary Breast Cancer? Patient Perceptions of Barriers Following a Referral Letter.
    Kne A; Zierhut H; Baldinger S; Swenson KK; Mink P; Veach PM; Tsai ML
    J Genet Couns; 2017 Aug; 26(4):697-715. PubMed ID: 27826805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. African American women's limited knowledge and experiences with genetic counseling for hereditary breast cancer.
    Sheppard VB; Graves KD; Christopher J; Hurtado-de-Mendoza A; Talley C; Williams KP
    J Genet Couns; 2014 Jun; 23(3):311-22. PubMed ID: 24186304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "I think that a brief conversation from their provider can go a very long way": Patient and provider perspectives on barriers and facilitators of genetic testing after ovarian cancer.
    Mallen AR; Conley CC; Fuzzell L; Ketcher D; Augusto BM; McIntyre M; Barton LV; Townsend MK; Fridley BL; Tworoger SS; Wenham RM; Vadaparampil ST
    Support Care Cancer; 2021 May; 29(5):2663-2677. PubMed ID: 32975643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitudes towards a programme of risk assessment and stratified management for ovarian cancer: a focus group study of UK South Asians' perspectives.
    Hann KEJ; Ali N; Gessler S; Fraser LSM; Side L; Waller J; Sanderson SC; Lanceley A;
    BMJ Open; 2018 Jul; 8(7):e021782. PubMed ID: 30021754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptability of HIV self-sampling kits (TINY vial) among people of black African ethnicity in the UK: a qualitative study.
    Dodds C; Mugweni E; Phillips G; Park C; Young I; Fakoya I; Wayal S; McDaid L; Sachikonye M; Chwaula J; Flowers P; Burns F
    BMC Public Health; 2018 Apr; 18(1):499. PubMed ID: 29653536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A qualitative study on Singaporean women's views towards breast cancer screening and Single Nucleotide Polymorphisms (SNPs) gene testing to guide personalised screening strategies.
    Wong XY; Chong KJ; van Til JA; Wee HL
    BMC Cancer; 2017 Nov; 17(1):776. PubMed ID: 29162038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosocial barriers and facilitators for cascade genetic testing in hereditary breast and ovarian cancer: a scoping review.
    Afaya A; Kim SW; Park HS; Lim MC; Jung MS; Nam EJ; Park JS; Jeong J; Ryu JM; Kim J; Kim J; Kim M; Jin J; Han J; Kim SY; Park SY; Katapodi MC; Kim S;
    Fam Cancer; 2024 Jun; 23(2):121-132. PubMed ID: 38662264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparities in genetics assessment for women with ovarian cancer: Can we do better?
    Manrriquez E; Chapman JS; Mak J; Blanco AM; Chen LM
    Gynecol Oncol; 2018 Apr; 149(1):84-88. PubMed ID: 29605055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.